Infectious Burden and Risk of Stroke: The Northern Manhattan Study
Arch Neurol 67:33-38, 16, Elkind,M.,et al, 2010
Herpes Zoster Ophthalmicus and the Risk of Stroke: A Population-Based Follow-up Study
Neurol 74:792-797, 788, Lin, H.-C.,et al, 2010
Neurotropic Viruses and Cerebral Palsy: Population Based Case-Control Study
BMJ 332:76-79,63, Gibson,C.S.,et al, 2006
Epstein-Barr Virus in Pediatric Multiple Sclerosis
JAMA 291:1875-1879, Alotaibi,S.,et al, 2004
Multiple Sclerosis and Epstein-Barr Virus
JAMA 289:1533-1536, Levin,L.I.,et al, 2003
Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis
JAMA 286:3083-3088,3127, Ascherio,A.,et al, 2001
Clinicopathologic Conference, Human Herpesvirus 6-Related Meningoencephalitis
NEJM 378:659-669, Case 5-2018, 2018
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 376:221-234,280, Hauser, S.L.,et al, 2017
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
NEJM 376:209-220,280, Montalban, X.,et al, 2017
Multiple Sclerosis Rebound Following Herpes Zoster Infection and Suspension of Fingolimod
Neurol 79:2006-2007,1942, Gross, C.M.,et al, 2012
Varicella-Zoster Virus Encephalitis and Vasculopathy in a Patient Treated with Fingolimod
Neurol 79:2002-2004,1942, Ratchford, J.,et al, 2012
Alemtuzumab for Multiples Sclerosis: Who and When to treat?
Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012
Lupus and Zoster
Lancet 362:616, Douglas,K.M.J., 2003
The Expanding Spectrum of Herpesvirus Infections of the Nervous System
Brain Pathol 11:440-451, Kleinschmidt-DeMasters,B.K. &Gilden,D.H., 2001
Neurologic Manifestations of AIDS
Medicine 66:407-437, McArthur,J.C., 1987
Drugs Five Years Later:Acyclovir
Ann Int Med 107:859-874, Dorsky,D.I.&Crumpacker,C.S., 1987
Herpes Zoster Ophthalmicus with Contralateral Hemiplegia
Arch Neurol 34:640, Pratesi,R.,et al, 1977